Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 0.00
   
  • Closing Price Chg:
    $3.20
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 0
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 116.78
Closing Price Change $ 3.20
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 1,246.00m
RiskGrade 120

Trades for 08-Oct-2025

Time Volume / Share Price
10:25 125 @ $116.60
10:25 215 @ $116.63
10:25 100 @ $116.61
10:25 100 @ $116.61
10:25 100 @ $116.59

Top of Page